Role of Macrophage Regulatory Cells (Mac-regs) in Immune Regulation
巨噬细胞调节细胞 (Mac-regs) 在免疫调节中的作用
基本信息
- 批准号:8106627
- 负责人:
- 金额:$ 37.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAnimalsAutoimmunityBehaviorBiologicalBiological ProcessBone MarrowCell physiologyCellsDataDevelopmentDiseaseEquilibriumGenomicsGoalsGrowthHypersensitivityITGAM geneImmuneImmune ToleranceImmune responseImmune systemImmunityLeadLearningLiverMediatingMetastatic LesionMusOrgan TransplantationPopulationPrimary NeoplasmRegulationRoleSpleenStagingT-Cell ProliferationT-LymphocyteTestingThymus GlandTimeTime StudyTissuesTumor ImmunityTumor Promotionbasecytokinedesignin vivoinsightlymph nodesmacrophagemicrobialneoplastic celloral toleranceperipheral bloodpreventtumortumor growthtumor progression
项目摘要
DESCRIPTION (provided by applicant): We have identified a new population of CD11b+F4/80+CD68+ (macrophages) that express Foxp3. Our initial results indicate that these cells were observed in spleen, lymph nodes, bone marrow, thymus, peripheral blood, liver and other tissues. We devised a strategy to highly purify CD11b+F4/80+Foxp3+ macrophages using the Foxp3-GFP mice. Our results show that CD11b+F4/80+ macrophages expressing Foxp3 inhibited the proliferation of T cells whereas Foxp3neg macrophages did not. Foxp3pos macrophages inhibited the proliferation of T cells through cell: cell contact mechanisms or soluble factors. Ablation of Foxp3 expression on CD11b+F4/80+Foxp3+ cells results in their lost capacity to inhibit the proliferation of T cells confirming that Foxp3 is directly responsible for conferring suppressive capabilities to this subpopulation of macrophages. The cytokine and genomic profiles of Foxp3pos and Foxp3neg macrophages were distinctive indicating that these cells have different biological functions. Furthermore, Foxp3pos macrophages induce de novo conversion Tregs, in contrast Foxp3neg macrophages did not. Functional analysis indicated that CD11b+F4/80+Foxp3+ macrophages are important for tolerance induction and are involved as well in tumor promotion and progression. For the first time, these studies demonstrate the existence of a distinct subpopulation of naturally occurring macrophage regulatory cells (Mac-regs) in which their suppressive function is directly correlated to the expression of Foxp3. Taken together our preliminary results lead to hypothesize that CD11b+F4/80+Foxp3+ cells (Mac-regs) subpopulation is an important subset of regulatory cells critical in the homeostatic balance of the immune system regulating immune responses which contribute to T cell tolerance induction and tumor promotion/growth. In order to test our hypothesis the following specific aims will be addressed: Aim 1 will define the mechanisms by which Mac-regs inhibit other cells; Aim 2 will evaluate the mechanism of tolerance induction by Mac-regs; and Aim 3 will evaluate the role of Mac-regs in tumor promotion and growth.
PUBLIC HEALTH RELEVANCE: For the first time we have identified a population of macrophages that express Foxp3. The Foxp3+ MX are able to inhibit the effector function of T cells. In vivo biological functions of Foxp3+ MX indicate that these induce immune tolerance and are important in promoting tumor growth. These results indicate that Foxp3+ MX are an important subset of regulatory cells critical in the homeostatic balance of the immune system. Learning more about the behavior of Foxp3+ MX is critical to understand the pathological function of these cells which could be related to tolerance, autoimmunity, tumor immunity, organ transplantation, allergy, and microbial immunity.
描述(由申请方提供):我们已经鉴定了一种表达Foxp 3的新的CD 11b +F4/80+ CD 68+(巨噬细胞)群体。我们的初步结果表明,这些细胞在脾脏,淋巴结,骨髓,胸腺,外周血,肝脏和其他组织中观察到。我们设计了一种使用Foxp 3-GFP小鼠高度纯化CD 11b +F4/80+ Foxp 3+巨噬细胞的策略。我们的结果表明,表达Foxp 3的CD 11b +F4/80+巨噬细胞抑制T细胞的增殖,而Foxp 3阴性巨噬细胞没有。Foxp 3 pos巨噬细胞通过细胞:细胞接触机制或可溶性因子抑制T细胞增殖。CD 11b +F4/80+ Foxp 3+细胞上Foxp 3表达的消除导致其抑制T细胞增殖的能力丧失,证实Foxp 3直接负责赋予该巨噬细胞亚群抑制能力。Foxp 3 pos和Foxp 3 neg巨噬细胞的细胞因子和基因组谱是不同的,表明这些细胞具有不同的生物学功能。此外,Foxp 3 pos巨噬细胞诱导从头转化TcB,相反Foxp 3 neg巨噬细胞不诱导。功能分析表明CD 11b +F4/80+ Foxp 3+巨噬细胞对于耐受诱导很重要,并且也参与肿瘤的促进和进展。这些研究第一次证明了天然存在的巨噬细胞调节细胞(Mac-tumor)的不同亚群的存在,其中它们的抑制功能与Foxp 3的表达直接相关。综上所述,我们的初步结果导致假设CD 11b +F4/80+ Foxp 3+细胞(Mac-Foxp 3+)亚群是调节免疫应答的免疫系统的稳态平衡中至关重要的调节细胞的重要子集,所述免疫应答有助于T细胞耐受诱导和肿瘤促进/生长。为了验证我们的假设,将解决以下具体目标:目标1将定义Mac-R2抑制其他细胞的机制;目标2将评估Mac-R2诱导耐受的机制;目标3将评估Mac-R2在肿瘤促进和生长中的作用。
公共卫生相关性:我们首次发现了表达Foxp 3的巨噬细胞群体。Foxp 3 + MX能够抑制T细胞的效应子功能。Foxp 3 + MX的体内生物学功能表明,它们诱导免疫耐受并且在促进肿瘤生长中是重要的。这些结果表明,Foxp 3 + MX是免疫系统稳态平衡中至关重要的调节细胞的重要子集。了解更多关于Foxp 3 + MX的行为对于了解这些细胞的病理功能至关重要,这些细胞可能与耐受,自身免疫,肿瘤免疫,器官移植,过敏和微生物免疫有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER A COHEN其他文献
PETER A COHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER A COHEN', 18)}}的其他基金
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
胰腺癌化疗与免疫疗法的最佳配对
- 批准号:
8738913 - 财政年份:2014
- 资助金额:
$ 37.58万 - 项目类别:
Role of Macrophage Regulatory Cells (Mac-regs) in Immune Regulation
巨噬细胞调节细胞 (Mac-regs) 在免疫调节中的作用
- 批准号:
8309017 - 财政年份:2011
- 资助金额:
$ 37.58万 - 项目类别:
Role of Macrophage Regulatory Cells (Mac-regs) in Immune Regulation
巨噬细胞调节细胞 (Mac-regs) 在免疫调节中的作用
- 批准号:
8501323 - 财政年份:2011
- 资助金额:
$ 37.58万 - 项目类别:
Role of Macrophage Regulatory Cells (Mac-regs) in Immune Regulation
巨噬细胞调节细胞 (Mac-regs) 在免疫调节中的作用
- 批准号:
8708747 - 财政年份:2011
- 资助金额:
$ 37.58万 - 项目类别:
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
用于过继免疫治疗的抗肿瘤 Th1 和 Tc1 的优化离体扩增
- 批准号:
8475569 - 财政年份:2009
- 资助金额:
$ 37.58万 - 项目类别:
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
用于过继免疫治疗的抗肿瘤 Th1 和 Tc1 的优化离体扩增
- 批准号:
8720513 - 财政年份:2009
- 资助金额:
$ 37.58万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Research Grant